Global healthcare provider Eli Lilly and Company and the Korean pharmaceutical company Hanmi Pharmaceutical Co., Ltd. signed an exclusive license and collaboration agreement focused on accelerating the development process and commercialization of a potential treatment for autoimmune and other conditions, such as lupus. The oral drug was developed by Hanmi and is expected…
In a recent commentary titled “Dialogue: Vitamin D, statins and atherosclerotic progression in pediatric lupus” published in BMJ Lupus Science & Medicine, Gary Gilkeson from the Medical University of South Carolina and Sue Manzi from the Temple University School of Medicine discuss the…
Felicia Day, Zachary Levi, Online Communications Manager Sophie Yan and friends The Lupus Foundation of America organized a fundraising and awareness event on the newly-launched entertainment company Geek & Sundry’s Twitch.tv channel. Personalities of Geek & Sundry hosted the event, which had over a million views…
Researchers at the Hopkins Lupus Center at Johns Hopkins University School of Medicine recently found that corticosteroids can be effective in fighting inflammations associated with lupus. However, according to the new study, adverse events from high doses can damage organs. These new findings may guide clinicians on the optimal dosing of…
HealthTell™, an early stage Life Sciences company, recently announced Chaim Putterman, M.D and John Galgiani, M.D as newly appointed clinical advisors. The company has developed a new technology named Immunosignature™ that accurately detects and monitors chronic illnesses, including Lupus. HealthTell is working on the first platform to diagnose and assess…
Patients who live with chronic diseases such as lupus often suffer with the burden of having to pay for expensive treatments every month. In order to help families deal with this issue, the Lupus Foundation of America has published an article on its blog…
A private supporter of novel lupus research, the Lupus Research Institute (LRI) is celebrating its 15th anniversary with the announcement of a series of grants awarded in recognition of new talent, diversity and excellency. Twelve Novel Research Grants were awarded within the categories of “Strategies for Better, Safer Treatments,” “Innovative Technologies…
The Strategic Pharma-Academic Research Consortium for Translational Medicine (SPARC) is going to provide more than $1.9 million to support studies on autoimmune diseases. The grant will be given to medical research universities located in the Midwest. The Indiana Clinical and Translational Sciences Institute leads SPARC, and the investigations will focuse…
Findings from a recent study in mice suggest that neonatal colonization of gut microbiota influences generalized autoimmunity in adult life, which may have implications for conditions such as Systemic Lupus Erythematosus. Researchers from Ghent University Hospital in Belgium found that upon increased levels of segmented filamentous bacteria, an alteration in…
A research team from the University Hospital Hamburg Eppendorf in Germany recently discovered an important pathway that may protect healthy tissue from immune responses. These findings can potentially help doctors provide better treatments for patients with autoimmune conditions such as Lupus. The immune system responds to inflammation by over-activation in…